Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Erzsebet Szabo
Lysophosphatidic Acid Type 2 Receptor Agonists in Targeted Drug Development Offer Broad Therapeutic Potential
Journal of Lipid Research
Biochemistry
Endocrinology
Cell Biology
Related publications
Targeted Lysophosphatidic Acid Receptor Antagonists for Hepatocellular Carcinoma Chemoprevention
HPB
Hepatology
Gastroenterology
Liver X Receptor Agonists as Potential Therapeutic Agents for Dyslipidemia and Atherosclerosis
Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular Medicine
Cardiology
Lysophosphatidic Acid Receptor 1 (LPAR1; EDG2; LPA1)
Science-Business eXchange
Tumor Necrosis Factor Receptor 2: A Potential Target for Antidepressant Drug Development
Clinical and Experimental Neuroimmunology
Neuroscience
Neurology
Immunology
Microbiology
Neurobiology of the Edg2 Lysophosphatidic Acid Receptor.
The Japanese Journal of Pharmacology
Polyunsaturated Lysophosphatidic Acid as a Potential Asthma Biomarker
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Therapeutic Applications of TRAIL Receptor Agonists in Cancer and Beyond
Pharmacology and Therapeutics
Pharmacology
Characterization of a Receptor Subtype-Selective Lysophosphatidic Acid Mimetic
Molecular Pharmacology
Molecular Medicine
Pharmacology
Cardiovascular Risk Reduction in Type 2 Diabetes: Therapeutic Potential of Dapagliflozin
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal Medicine
Pharmacology